0001104659-16-097480.txt : 20160216
0001104659-16-097480.hdr.sgml : 20160215
20160216183042
ACCESSION NUMBER: 0001104659-16-097480
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20160211
FILED AS OF DATE: 20160216
DATE AS OF CHANGE: 20160216
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: CATABASIS PHARMACEUTICALS INC
CENTRAL INDEX KEY: 0001454789
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: ONE KENDALL SQUARE
STREET 2: BLDG. 1400E, SUITE B14202
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
BUSINESS PHONE: 617-349-1971
MAIL ADDRESS:
STREET 1: ONE KENDALL SQUARE
STREET 2: BLDG. 1400E, SUITE B14202
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Milne Jill C.
CENTRAL INDEX KEY: 0001644246
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37467
FILM NUMBER: 161430898
MAIL ADDRESS:
STREET 1: C/O CATABASIS PHARMACEUTICALS, INC.
STREET 2: ONE KENDALL SQ., BLDG. 1400E, STE.B14202
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
4
1
a4.xml
4
X0306
4
2016-02-11
0
0001454789
CATABASIS PHARMACEUTICALS INC
CATB
0001644246
Milne Jill C.
C/O CATABASIS PHARMACEUTICALS, INC.
ONE KENDALL SQ., BLDG 1400E, STE B14202
CAMBRIDGE
MA
02139
1
1
0
0
President and CEO
Stock Option (right to buy)
4.57
2016-02-11
4
A
0
103000
0
A
2026-02-10
Common Stock
103000
103000
D
This option was granted on February 11, 2016 and is scheduled to vest over four years, with 25% of the shares vesting on the first anniversary of February 11, 2016 and the remainder vesting over the ensuing three years at a rate of 2.0833% per month.
/s/ Ian C. Sanderson, as attorney-in-fact for Jill C. Milne
2016-02-16